Rare and ‘unusual’ cancers are emerging after the Covid pandemic – and doctors fear an unlikely culprit is to blame

Doctors across the US are reporting an alarming health trend in the wake of the pandemic.   

Since about 2021, they are noticing rare and unusual cancers in patients who shouldn’t fit the bill – many of them young and without any family history of disease. 

Cancers that typically affect seniors in their 70s, and 80s are now striking people in their 40s, including bile duct and rare blood cancers.

The pandemic forced people to isolate and put off preventative care measures that would screen for various types of cancers, out of fear of being infected.

But doctors do not believe this to be the primary driver of advanced, rare cancer cases. Instead, they posit that Covid itself is to blame.  

The Kralls also learned that several of their neighbors had been diagnosed with the same rare cancers. Photo courtesy of Mrs Krall’s Facebook page

Dr Kashyap Patel, a North Carolina oncologist, has seen this firsthand. He saw a patient in his 40s in 2021 who had a rare cancer of the bile ducts, which transport fluid produced by the liver to the small intestine, where it aids in the absorption and digestion of fats.

This type of cancer typically affects people in their 70s and 80s. 

Then, multiple other patients he met with were diagnosed with an array of different cancers, something he said he has never seen in his two decades of practicing medicine. 

One couple he investigated were Bob and Bonnie Krall of Fort Mill, South Carolina, who in a 14 month period were diagnosed with three types of cancer between them despite having no genetic predisposition.

Mr Krall was diagnosed with a rare chronic blood and bone marrow cancer, while Mrs Krall had a malignancy in her abdomen weighing eight and a half pounds, according to the Washington Post.

Mr Krall later learned that several of his neighbors had the same type of cancer: ‘It’s like a cold. It seems like everyone has it.’

Dr Kashyap Patel, a North Carolina oncologist, has treated patients in their 40s with rare and advanced cancers post-Covid

Viruses have been known to accelerate cancer since the 1960s, and researchers contend that a quarter of all cancers worldwide originated with HPV, Epstein-Barr virus, and hepatitis B.

Researchers have focused on the effects of Covid itself as well as lingering symptoms even after recovering, a phenomenon known as long Covid. 

They have not, however, uncovered links between the Covid vaccines and cancer risk, though research into the long-term effects of vaccines is ongoing. 

They’re not exactly sure why vaccines do not appear to be linked to cancers, but one possible explanation could be that Covid vaccines, even the viral vector vaccine from Johnson & Johnson, do not contain the live virus which could in rare instances lead to illness. 

Science has shown that coronavirus proteins fuel the replication of various viruses known to reawaken dormant cancer cells, increasing the odds of being diagnosed with breast, stomach, and blood cancers.

Research into the links between Covid and cancer is relatively new, given the pandemic began only four years ago. 

A 2023 report in the journal Biochimie detailed different means by which the coronavirus the coronavirus can change genes that usually stop tumors from forming and cause widespread inflammation throughout the body. 

This inflammation might lead to the development of cancer cells in various organs, including the lungs, pancreas, and colon.

The photo shows the coronavirus indicated in yellow, emerging from the surface of cells, indicated in blue/pink, cultured in a laboratory. Research suggests that the virus can reawaken dormant cancer cells, and cause whole body inflammation that can lead to the proliferation of cancer cells

The above graph shows the change in cancer case rates around the world

And a team in Colorado has begun probing the possibility that the coronavirus brings cancer cells to life in mice. 

A preprint released in April showed that when mice who had cancer previously but recovered were injected with the coronavirus, cancer cells multiplied and spread in the lungs.

The flu virus was shown to do the same thing. Researchers such as Dr Ashani Weeraratna of the Johns Hopkins Bloomberg School of Public Heath, were not exactly surprised by this finding.

She said that it makes sense that ‘something like influenza or Covid that triggers inflammation could change in the immune microenvironment,’ adding, ‘it’s rare the data are so striking.’

Dr Weeraratna said: ‘Mitigating risk of infection may be of particular importance for cancer patients,’ Weeraratna said.

Based on the study’s findings, measures adopted by vulnerable patients starting in the early days of the pandemic — wearing masks, avoiding crowded places, getting vaccines — become even more important.’

Dr Patel is now researching the connection himself. Based on data from over 300 patients, his office have logged over 15 patients with multiple cancers, about 35 who had rare cancers, and 15 couples with new cancers since the pandemic began four years ago.

He posited that being infected with the virus more than once has an even greater impact, as did pandemic-related stress by exacerbating whole-body inflammation that could reactivate cancer cells.

Even during the first wave of the Covid pandemic up to December 31, 2020 doctors began noticing an uptick in cancer cases.

A 2023 report in the journal Lancet Oncology looked at 2.4 million adults who had been diagnosed with cancer in 2018, 2019, and 2020. New cancer cases fell after the start of the pandemic, but ticked back up at the end of the year.

The odds of being diagnosed with an advanced stage 4 cancer was more than seven percent higher in 2020 compared to the previous year.

Dr Xuesong Han, a top researcher at the American Cancer Society and lead author of the Lancet Oncology study, said that biological mechanisms underpinning the coronavirus could be at play.

He said: ‘I don’t have the data to support this opinion. But it’s an important question to follow up on.’